Filtern
Erscheinungsjahr
- 2014 (232) (entfernen)
Dokumenttyp
- Wissenschaftlicher Artikel (232) (entfernen)
Sprache
- Englisch (225)
- Deutsch (5)
- Mehrsprachig (1)
- Rumänisch (1)
Volltext vorhanden
- ja (232)
Gehört zur Bibliographie
- nein (232) (entfernen)
Schlagworte
- Multimorbidity (4)
- Decorin (3)
- Depression (3)
- Primary care (3)
- ATM (2)
- Aortic valve replacement (2)
- Breast cancer (2)
- Cancer (2)
- Chronic disease (2)
- Drug hepatotoxicity (2)
- Drug induced liver injury (2)
- Family practice (2)
- General practice (2)
- HER2 (2)
- IR-A (2)
- Inflammation (2)
- Outcome (2)
- Proliferation (2)
- Signaling (2)
- apoptosis (2)
- 1α,25(OH)2D3 (1)
- 4-1BB (1)
- 99mTc-MIBI (1)
- 99mTc-pertechnetate (1)
- A/D transition (1)
- ABCB1 (1)
- ABCC1 (1)
- ABCG2 (1)
- ARID5B (1)
- ATP (1)
- Accelerometry (1)
- Acquired drug resistance (1)
- Adult T-cell acute lymphoblastic leukemia (1)
- Advanced biliary tract cancer (1)
- Agreement (1)
- All oral (1)
- Allograft bone block (1)
- Alpha-synuclein (1)
- Alzheimer (1)
- Amyloid precursor protein (1)
- Aneurysm (1)
- Angiogenesis (1)
- Anopheles (1)
- Anti-TNF (1)
- Antiviral therapy (1)
- Aortic valve (1)
- Assessment of care (1)
- Auditory (1)
- Autogenous bone block (1)
- Autonomic nervous system (1)
- Autophagy (1)
- BCL11b (1)
- BPDCN (1)
- BTC (1)
- Biglycan (1)
- Biological heart valves (1)
- Biological markers (1)
- Biomarker (1)
- Bioprosthesis (1)
- Bipolar (1)
- Bipolar disorder (1)
- Bone regeneration (1)
- Breast conserving surgery (1)
- CD137 (1)
- CD8+ T-cell mediated tumor suppression (1)
- CDKN2A (1)
- CEBPE (1)
- CV9202 (1)
- CY-503 (1)
- Cancer staging (1)
- Cardiac function (1)
- Cardiovascular mortality (1)
- Carrier-bound fibrin sealant (1)
- Causality assessment (1)
- Cell cycle (1)
- Cell plasticity (1)
- Cell proliferation (1)
- Cellular (1)
- Cerebellar ataxia (1)
- Chemokine CCL2 (1)
- Chemokines (1)
- Chromoendoscopy (1)
- Chronic Hepatitis C (1)
- Chronic care model (1)
- Chronic diseases (1)
- Chronic hepatitis C (1)
- Chronic medical conditions (1)
- Chronic pancreatitis (1)
- Citationrate (1)
- Classification (1)
- Clinical efficacy (1)
- Clinical studies (1)
- Clinical trial (1)
- Cluster randomization (1)
- Coexistence (1)
- Collagen hemostat (1)
- Collagen type I (1)
- Collagen type III (1)
- Colorectal cancer (1)
- Comorbidity (1)
- Complex I (1)
- Complexin-1 (1)
- Confocal endomicroscopy (1)
- Conformational change (1)
- Coping (1)
- Creeping Disease (1)
- Cross-sectional (1)
- Cytoskeletal proteins (1)
- D2-autoreceptor (1)
- DAA (1)
- DKTK-ROG (1)
- DMARDs (biologic) (1)
- DNA damage (1)
- DNA mismatch repair (1)
- DTI (1)
- Daptomycin (1)
- Dataset bias (1)
- Decision making (1)
- Dendritic cells (1)
- Density-equalizing mapping (1)
- Diabetes mellitus (1)
- Diagnosis (1)
- Diagnostik (1)
- Dicer (1)
- Diffuse large B cell lymphoma (1)
- Direct-acting antiviral agents (DAAs) (1)
- Disease Activity (1)
- Drug (1)
- Drug development (1)
- Drugs (1)
- EBM (1)
- EGFR (1)
- EQ-5D (1)
- ES cells (1)
- Elderly patients (1)
- Electrical instability (1)
- Electronic cigarettes (1)
- Endometrial cancer (1)
- Endoscopic retrograde Cholangiopancreatography (ERCP) (1)
- Endothelial cells (1)
- Ethnicity (1)
- Everolimus resistance (1)
- Evidenzbasierte Medizin (1)
- Exercise testing (1)
- Expression (1)
- FSS (1)
- Fbw7 (1)
- Fibroblasts (1)
- Fingolimod (1)
- Foxp1 (1)
- Frontotemporal dementia (1)
- Functional connectivity (1)
- Functionally-impaired elderly (1)
- GM-CSF (1)
- GRADE (1)
- Gastric cancer (1)
- Gaussian graphical models (1)
- Gene expression (1)
- Gene-protein assay (1)
- GeneMANIA (1)
- Genetics (1)
- Glucocorticoids (1)
- Goal-oriented care (1)
- Graphical LASSO (1)
- Guided tissue regeneration (1)
- H-Index (1)
- H5N1 (1)
- HDAC (1)
- HDAC-inhibition (1)
- HNSCC (1)
- HPV (1)
- Hand-foot syndrome (1)
- Hard-to-reach population (1)
- Health care access (1)
- Health services research (1)
- Health-related quality of life (1)
- Healthcare personnel (1)
- Heat Shock Protein (HSP) (1)
- Hemostatics (1)
- Heparan Sulfate (1)
- Herb induced liver injury (1)
- Herbal hepatotoxicity (1)
- Hif-1 alpha (1)
- Hif1α (1)
- High-density lipoprotein (1)
- Hippocampus (1)
- Hospital (1)
- Host-targeting agents (HTAs) (1)
- Hyaluronan (1)
- IBD (1)
- IKZF1 (1)
- IL-12 (1)
- Immunohistochemistry (1)
- In vitro (1)
- Infant leukemia (1)
- Infants (1)
- Infektionsabwehr (1)
- Inflammasome (1)
- Influenza vaccination (1)
- Inner ear therapy (1)
- Insulin therapy (1)
- Interferon-free HCV treatment (1)
- Intratympanic drug delivery (1)
- KRAS (1)
- Knockout (1)
- L1-norm SVM (1)
- LHRH receptor (1)
- LUBAC (1)
- LVAD (1)
- Leitlinie (1)
- Lipid trafficking (1)
- Liver resection (1)
- Long term result (1)
- Long-term follow up (1)
- Longitudinal analysis (1)
- Low-dose X-irradiation (1)
- Lymphangiogenesis (1)
- MCAK (1)
- MEG (1)
- MKP1 (1)
- MLH1 (1)
- MLL (1)
- MMP9 (1)
- MPM (1)
- MRSA (1)
- Maintenance treatment (1)
- Major depressive disorder (1)
- Mania (1)
- Mcl-1 (1)
- Melanoma (1)
- Menthol (1)
- Metastatic breast cancer (1)
- Microarray (1)
- Midbrain/brainstem expression changes (1)
- Migrants (1)
- Mitoxantrone (1)
- Molecular subtypes (1)
- Mortality (1)
- Motor neuron disease (1)
- Multidetector computed tomography (1)
- Mutation (1)
- Myelin or myeloarchitecture (1)
- Myeloperoxidase (1)
- Myotonic dystrophy (1)
- N-acetyl-L-cysteine (1)
- N-hydroxysuccinimide (1)
- NADH:ubiquinone oxidoreductase (1)
- NFAT (1)
- NFκB (1)
- NKG2D (1)
- NRAS (1)
- NS3/4A protease inhibitors (PI) (1)
- NS5A inhibitors (1)
- Necrosis (Necrotic Death) (1)
- Neoadjuvant systemic therapy (1)
- Neoplasms (1)
- Neuronal morphology (1)
- Nicotine (1)
- Nodular lymphocyte predominant Hodgkin lymphoma (1)
- Non-aneurysmal (1)
- Non-nucleoside polymerase inhibitors (NNI) (1)
- Non-perimesencephalic (1)
- Observational study (1)
- Oral anticoagulation (1)
- Oxygen uptake (1)
- PDCD4 (1)
- PDGFRβ (1)
- PLX4032 (1)
- PLX4720 (1)
- PROMISE (1)
- PTEN (1)
- Paediatric Investigation Plan (1)
- Paediatric oncology (1)
- Pain (1)
- Parkinsons disease (1)
- Parkinson’s disease (1)
- Pathologic complete response (1)
- Patient care planning (1)
- Patient preference (1)
- Patient-centered care (1)
- Patient-centred care (1)
- Patients (1)
- Perilymph (1)
- Perimesencephalic (1)
- Phase 2 (1)
- Physician report (1)
- Pink esthetic score (1)
- Plasma (1)
- Plasmodium (1)
- Plastic endoprosthesis (1)
- Plk1 (1)
- Plk1 inhibitors (1)
- Polarity index (1)
- Pooling (1)
- Postoperative radiochemotherapy (1)
- Precompetitive development (1)
- Predominant polarity (1)
- Prepontine (1)
- Presynaptic vesicles (1)
- Prostatic neoplasms (1)
- Protein tyrosine modification (1)
- QA/QC (1)
- Quality of life (1)
- Quantitative MRI (1)
- Questionnaire (1)
- RNA interference (1)
- RNA processing machinery (1)
- RNActive (1)
- ROS (1)
- Radiotherapy (1)
- Randomized controlled trial (1)
- Reconstruction (1)
- Regeneration (1)
- Regulatory framework (1)
- Renal cell carcinoma (1)
- Reproducibility/stability (1)
- Resting state (1)
- Rheumatoid Arthritis (1)
- Risk factor (1)
- Risk stratification (1)
- Round window membrane (1)
- SAH close (1)
- SOD (1)
- SPTAN1 (1)
- STAT5 (1)
- Sauerstoffpartialdruck (1)
- Schizophrenia (1)
- Scientometria (1)
- Selenium (1)
- Selenoproteins (1)
- Self-assessment (1)
- Self-expandable metal stent (SEMS) (1)
- Self-report (1)
- Sharpin (1)
- Silicosis (1)
- Silver in situ hybridization (1)
- Small Leucine-rich Proteoglycan (SLRP) (1)
- Social support (1)
- Sociocognitive predictors (1)
- Sorafenib (1)
- Source reconstruction (1)
- Sparse models (1)
- Sphingosine-1-phosphate (1)
- Spine density (1)
- Standard risk (1)
- Subarachnoid hemorrhage (1)
- Sudden cardiac death (1)
- Supplementation (1)
- Survival analysis (1)
- TIA-1 (1)
- TMC435 (1)
- TNFR1 (1)
- TRAIL (1)
- Targeted therapy (1)
- Th1 polarization (1)
- Therapie (1)
- Thyroid disease (1)
- Tissue engineering (1)
- Toll-like Receptor (TLR) (1)
- Tracheal Intubation (1)
- Transcatheter based aortic valve implantation (1)
- Transcriptome (1)
- Transformation (1)
- Trastuzumab (1)
- Triamcinolone acetonide (1)
- Tumor growth (1)
- Tumor microenvironment (1)
- Ureter (1)
- Urothelial cells (1)
- VBM (1)
- VDR (1)
- VEGFR (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vein (1)
- Veino-lymphatic separation (1)
- Vemurafenib (1)
- Video (1)
- Videolaryngoscopy (1)
- Vincristine (1)
- Wundheilung (1)
- ablation techniques (1)
- acute attacks (1)
- acute lung injury (1)
- adaptive immune escape (1)
- adenovirus (1)
- adipose-derived stem cells (ASCs) (1)
- adjuvant chemotherapy (1)
- aging (1)
- albumin (1)
- amphiregulin (1)
- antitumor immunity (1)
- antiviral (1)
- apixaban (1)
- arsenic trioxide (1)
- arterial hypertension (1)
- astroglia (1)
- ataxia telangiectasia (1)
- aviscumine (1)
- baicalein (1)
- baroreflex (1)
- bibliometry (1)
- biochanin A (1)
- blastic plasmacytoid dendritic cell neoplasm (1)
- brain metastasis (1)
- breast (1)
- burden of illness (1)
- c-kit (1)
- cancer immunotherapy (1)
- carbapenemase (1)
- cardiovascular pharmacology (1)
- cdk2/cyclin A (1)
- cell biology (1)
- cell fate (1)
- cell identity (1)
- chemokines (1)
- chromosome alignment (1)
- chronic liver disease (CLD) (1)
- cigarette (1)
- citation (1)
- climate change (1)
- clinico-biological indices (1)
- cocaine (1)
- collaborative feedback (1)
- colloid (1)
- common neighbor (1)
- complex systems (1)
- comprehensive care (1)
- computerized programs (1)
- cone-beam computed tomography (CBCT) (1)
- cortex (1)
- cortical networks (1)
- cortical slices (1)
- cross-border (1)
- cross-communication (1)
- crystalloid (1)
- cyclooxygenase (1)
- cytotoxic immunotherapy (1)
- dabigatran (1)
- dendritic cell–tumor cell fusion (1)
- denervation (1)
- differentiation (1)
- distributed computation (1)
- edoxaban (1)
- education (1)
- educational theory (1)
- electromagnetic navigation bronchoscopy (EMN, ENB) (1)
- endothelin (1)
- endothelin receptor type A antagonist (1)
- environment (1)
- epidemiology (1)
- epigenetic memory (1)
- epigenetics (1)
- epiregulin (1)
- erythropoietin (1)
- fMRI (1)
- faculty development (1)
- fatigue (1)
- fluid (1)
- full-contour zirconia (1)
- gender studies (1)
- gene expression (1)
- glioma (1)
- gram-negative bacteria (1)
- graph theory (1)
- grinding (1)
- guanidine alkaloid (1)
- guideline (1)
- healthcare personnel (1)
- heart failure (1)
- hepatitis C virus (1)
- hepatocellular carcinoma (HCC) (1)
- hereditary angioedema (1)
- hereditary angioedema, (1)
- high-intensity focused ultrasound ablation (1)
- highly parallel recordings (1)
- histone modification (1)
- hospital (1)
- human intracranial recordings (1)
- hypertonic (1)
- hypoxia (1)
- immune escape (1)
- immune surveillance of cancer (1)
- immunology (1)
- imported malaria (1)
- individualized therapy (1)
- infection eradication (1)
- inflammation (1)
- influenza vaccination (1)
- information storage (1)
- inheritance (1)
- innate immune system (1)
- insecticide (1)
- intensive care (1)
- interleukins (1)
- irbesartan (1)
- isradipine (1)
- kutane Larva migrans (1)
- l-DOPA (1)
- leukemia initiating cell (1)
- liver (1)
- local information dynamics (1)
- local radiotherapy (1)
- long-term prophylaxis (1)
- mRNA vaccine (1)
- mTOR (1)
- macular hole (1)
- malaria elimination (1)
- mandatory reporting (1)
- medical education (1)
- medical teacher (1)
- melanoma (1)
- metastatic cancer (1)
- metastatic melanoma stage IV (1)
- miRNA (1)
- miRNA let-7e (1)
- microRNA (1)
- microplasmin (1)
- microtubule-targeting agents (1)
- monkeys (1)
- motifs (1)
- mouse (1)
- multidrug resistance (1)
- multiunit activity (1)
- mutually exclusive mutations (1)
- natural compounds (1)
- natural product (1)
- neocortex development (1)
- network topology (1)
- neural dynamics (1)
- neuroprotection (1)
- next generation sequencing (1)
- non-small cell lung cancer (1)
- nonrandom connectivity (1)
- ocriplasmin (1)
- oral anticoagulation (1)
- p16 (1)
- p21 (1)
- p53 (1)
- patient-reported outcomes (1)
- peginterferon-α (1)
- pharmacologic vitreolysis (1)
- phase II trial (1)
- polishing (1)
- population-based surveillance (1)
- posterior vitreous detachment (1)
- predictive biomarkers (1)
- predictive coding (1)
- pregnancy (1)
- productivity (1)
- prostate cancer cells (1)
- protein stability (1)
- pulmonary hypertension (1)
- qualitative research (1)
- quality of life (1)
- radiation (1)
- radionuclide imaging (1)
- reactive oxygen species (1)
- recommendations (1)
- recurrent mutations (1)
- remodelling (1)
- resistance (1)
- resource utilization (1)
- resuscitation (1)
- ribavirin (1)
- ribosome-inactivating protein (1)
- rivaroxaban (1)
- roughness (1)
- scientometry (1)
- self-administration (1)
- self-organized criticality (1)
- senescence (1)
- shock (1)
- short-term prophylaxis (1)
- simeprevir (1)
- simulation (1)
- skin inflammation (1)
- smoking (1)
- social cognitive (1)
- solitary pulmonary nodule (1)
- spike train analysis (1)
- spiking neural networks (1)
- spindle assembly (1)
- stage II/III colorectal cancer (1)
- subventricular zone (SVZ) (1)
- sympathetic nervous system (1)
- t(6;9) (1)
- the allen institute for brain science (1)
- therapy (1)
- thyroid nodule (1)
- training (1)
- transarterial chemoembolization (TACE) (1)
- transbronchial biopsy (TBB) (1)
- triple therapy (1)
- tumor infiltrating lymphocytes (1)
- tumor necrosis factor receptor superfamily member 9 (1)
- tumor response (1)
- tumor suppressor (1)
- tumor-specific antigen expressing dendritic cells (1)
- ubiquitin (1)
- vector (1)
- veneering porcelain (1)
- ventricular zone (VZ) (1)
- visual system (1)
- vitreomacular traction (1)
- voltage sensitive dye imaging (1)
- γH2AX (1)
Institut
- Medizin (232) (entfernen)
BACKGROUND: Transient episodes of ischemia in a remote organ or tissue (remote ischemic preconditioning, RIPC) can attenuate myocardial injury. Myocardial damage is associated with tissue remodeling and the matrix metalloproteinases 2 and 9 (MMP-2/9) are crucially involved in these events. Here we investigated the effects of RIPC on the activities of heart tissue MMP-2/9 and their correlation with serum concentrations of cardiac troponin T (cTnT), a marker for myocardial damage.
METHODS: In cardiosurgical patients with cardiopulmonary bypass (CPB) RIPC was induced by four 5 minute cycles of upper limb ischemia/reperfusion. Cardiac tissue was obtained before as well as after CPB and serum cTnT concentrations were measured. Tissue derived from control patients (N = 17) with high cTnT concentrations (≥0.32 ng/ml) and RIPC patients (N = 18) with low cTnT (≤0.32 ng/ml) was subjected to gelatin zymography to quantify MMP-2/9 activities.
RESULTS: In cardiac biopsies obtained before CPB, activities of MMP-2/9 were attenuated in the RIPC group (MMP-2: Control, 1.13 ± 0.13 a.u.; RIPC, 0.71 ± 0.12 a.u.; P < 0.05. MMP-9: Control, 1.50 ± 0.16 a.u.; RIPC, 0.87 ± 0.14 a.u.; P < 0.01), while activities of the pro-MMPs were not altered (P > 0.05). In cardiac biopsies taken after CPB activities of pro- and active MMP-2/9 were not different between the groups (P > 0.05). Spearman's rank tests showed that MMP-2/9 activities in cardiac tissue obtained before CPB were positively correlated with postoperative cTnT serum levels (MMP-2, P = 0.016; MMP-9, P = 0.015).
CONCLUSIONS: Activities of MMP-2/9 in cardiac tissue obtained before CPB are attenuated by RIPC and are positively correlated with serum concentrations of cTnT. MMPs may represent potential targets for RIPC mediated cardioprotection.
TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT00877305.
Plexins are widely expressed transmembrane proteins that mediate the cellular effects of semaphorins. The molecular mechanisms of plexin-mediated signal transduction are still poorly understood. Here we show that signalling via B-family plexins leading to the activation of the small GTPase RhoA requires activation of the IκB kinase (IKK)-complex. In contrast, plexin-B-dependent regulation of R-Ras activity is not affected by IKK activity. This regulation of plexin signalling depends on the kinase activity of the IKK-complex, but is independent of NF-κB activation. We confirm that the IKK-complex is active in tumour cells and osteoblasts, and we demonstrate that plexin-B-dependent tumour cell invasiveness and regulation of osteoblast differentiation require an active IKK-complex. This study identifies a novel, NF-κB-independent function of the IKK-complex and shows that IKK directs plexin-B signalling to the activation of RhoA.
Ziel: Die Evaluation der DEGUM-Mammasonografiekurse nach objektivierbaren Kriterien war Ziel dieser Arbeit. Damit sollte die Qualität der Kurse überprüft werden, um eine flächendeckende Fort- und Weiterbildung auf hohem Niveau anzubieten.
Material und Methoden: 10 Qualitätskriterien, orientierend an den Vorgaben der KBV-Ultraschallvereinbarungen wurden als Qualitätsparameter definiert. Alle Kursleiter des Arbeitskreises Mammasonografie der DEGUM wurden angeschrieben. Dabei wurden die 10 definierten Qualitätskriterien überprüft.
Ergebnisse: Alle Kurse erfüllten die Voraussetzungen bezüglich der Qualität des Kursleiters, der Kursdauer und Unterrichtseinheiten sowie der Anzahl an Kursteilnehmern pro Ultraschallgerät. In 1 von 9 Kursen wurde die Zeit der praktischen Übungen, gefordert sind 50 %, unterschritten. Die Voraussetzungen für den Abschlusskurs (200 selbst durchgeführte und dokumentierte Fälle) sind in den Kursankündigungen zum Teil nicht klar definiert. Ein strukturierter Lehrkatalog fehlt.
Schlussfolgerung: Die DEGUM-Mammasonografiekurse werden auf hohem Niveau angeboten und erfüllen zum größten Teil die Anforderungen der KBV. Trotz der hohen Qualität der DEGUM-Kurse sind Optimierungsoptionen im Bereich Kursankündigung und strukturierter Lehrkatalog möglich.
Changes in vitamin D serum levels have been associated with inflammatory diseases, such as inflammatory bowel disease (IBD), rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis (MS), atherosclerosis, or asthma. Genome- and transcriptome-wide studies indicate that vitamin D signaling modulates many inflammatory responses on several levels. This includes (i) the regulation of the expression of genes which generate pro-inflammatory mediators, such as cyclooxygenases or 5-lipoxygenase, (ii) the interference with transcription factors, such as NF-κB, which regulate the expression of inflammatory genes and (iii) the activation of signaling cascades, such as MAP kinases which mediate inflammatory responses. Vitamin D targets various tissues and cell types, a number of which belong to the immune system, such as monocytes/macrophages, dendritic cells (DCs) as well as B- and T cells, leading to individual responses of each cell type. One hallmark of these specific vitamin D effects is the cell-type specific regulation of genes involved in the regulation of inflammatory processes and the interplay between vitamin D signaling and other signaling cascades involved in inflammation. An important task in the near future will be the elucidation of the regulatory mechanisms that are involved in the regulation of inflammatory responses by vitamin D on the molecular level by the use of techniques such as chromatin immunoprecipitation (ChIP), ChIP-seq, and FAIRE-seq.
Background: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker.
Methods: Samples of 120 HDV-infected patients recruited in an international multicenter treatment trial (HIDIT-2) were studied. Anti-HDV IgM testing was performed using ETI-DELTA-IGMK-2-assay (DiaSorin). In addition, fifty cytokines, chemokines and angiogenetic factors were measured using multiplex technology (Bio-Plex System). A second independent cohort of 78 patients was studied for the development of liver-related clinical endpoints (decompensation, HCC, liver transplantation or death; median follow up of 3.0 years, range 0.6–12).
Results: Anti-HDV IgM serum levels were negative in 18 (15%), low (OD<0.5) in 76 (63%), and high in 26 (22%) patients of the HIDIT-2 cohort. Anti-HDV IgM were significantly associated with histological inflammatory (p<0.01) and biochemical disease activity (ALT, AST p<0.01). HDV replication was independent from anti-HDV IgM, however, low HBV-DNA levels were observed in groups with higher anti-HDV IgM levels (p<0.01). While high IP-10 (CXCL10) levels were seen in greater groups of anti-HDV IgM levels, various other antiviral cytokines were negatively associated with anti-HDV IgM. Associations between anti-HDV IgM and ALT, AST, HBV-DNA were confirmed in the independent cohort. Clinical endpoints occurred in 26 anti-HDV IgM positive patients (39%) but in only one anti-HDV IgM negative individual (9%; p = 0.05).
Conclusions: Serum anti-HDV IgM is a robust, easy-to-apply and relatively cheap marker to determine disease activity in hepatitis delta which has prognostic implications. High anti-HDV IgM levels may indicate an activated interferon system but exhausted antiviral immunity.
Information theory allows us to investigate information processing in neural systems in terms of information transfer, storage and modification. Especially the measure of information transfer, transfer entropy, has seen a dramatic surge of interest in neuroscience. Estimating transfer entropy from two processes requires the observation of multiple realizations of these processes to estimate associated probability density functions. To obtain these necessary observations, available estimators typically assume stationarity of processes to allow pooling of observations over time. This assumption however, is a major obstacle to the application of these estimators in neuroscience as observed processes are often non-stationary. As a solution, Gomez-Herrero and colleagues theoretically showed that the stationarity assumption may be avoided by estimating transfer entropy from an ensemble of realizations. Such an ensemble of realizations is often readily available in neuroscience experiments in the form of experimental trials. Thus, in this work we combine the ensemble method with a recently proposed transfer entropy estimator to make transfer entropy estimation applicable to non-stationary time series. We present an efficient implementation of the approach that is suitable for the increased computational demand of the ensemble method's practical application. In particular, we use a massively parallel implementation for a graphics processing unit to handle the computationally most heavy aspects of the ensemble method for transfer entropy estimation. We test the performance and robustness of our implementation on data from numerical simulations of stochastic processes. We also demonstrate the applicability of the ensemble method to magnetoencephalographic data. While we mainly evaluate the proposed method for neuroscience data, we expect it to be applicable in a variety of fields that are concerned with the analysis of information transfer in complex biological, social, and artificial systems.
Memory Concerns, Memory Performance and Risk of Dementia in Patients with Mild Cognitive Impairment
(2014)
Background: Concerns about worsening memory (“memory concerns”; MC) and impairment in memory performance are both predictors of Alzheimer's dementia (AD). The relationship of both in dementia prediction at the pre-dementia disease stage, however, is not well explored. Refined understanding of the contribution of both MC and memory performance in dementia prediction is crucial for defining at-risk populations. We examined the risk of incident AD by MC and memory performance in patients with mild cognitive impairment (MCI).
Methods: We analyzed data of 417 MCI patients from a longitudinal multicenter observational study. Patients were classified based on presence (n = 305) vs. absence (n = 112) of MC. Risk of incident AD was estimated with Cox Proportional-Hazards regression models.
Results: Risk of incident AD was increased by MC (HR = 2.55, 95%CI: 1.33–4.89), lower memory performance (HR = 0.63, 95%CI: 0.56–0.71) and ApoE4-genotype (HR = 1.89, 95%CI: 1.18–3.02). An interaction effect between MC and memory performance was observed. The predictive power of MC was greatest for patients with very mild memory impairment and decreased with increasing memory impairment.
Conclusions: Our data suggest that the power of MC as a predictor of future dementia at the MCI stage varies with the patients' level of cognitive impairment. While MC are predictive at early stage MCI, their predictive value at more advanced stages of MCI is reduced. This suggests that loss of insight related to AD may occur at the late stage of MCI.
Background: In this study, we examined patients who had non-progressive disease for at least 2 years after diagnosis of inoperable locoregional recurrent or metastatic breast cancer under continuous trastuzumab treatment. Our primary goal was to assess the long-term outcome of patients with durable response to trastuzumab.
Methods: 268 patients with HER2-positive inoperable locally recurrent or metastatic breast cancer and non-progressive disease for at least 2 years under trastuzumab treatment were documented retrospectively or prospectively in the HER-OS registry, an online documentation tool, between December 2006 and September 2010 by 71 German oncology centers. The study end point was time to tumor progression.
Results: Overall, 47.1% of patients (95% confidence interval (CI): 39.9–54.1%) remained in remission for more than 5 years, while the median time to progression was 4.5 years (95% CI: 4.0–6.6 years). Lower age (<50 years) and good performance status (ECOG 0) at time of trastuzumab treatment initiation as well as complete remission after initial trastuzumab treatment were associated with longer time to progression. Interruption of trastuzumab therapy correlated with shorter time to progression.
Conclusions: HER2-positive patients, who initially respond to palliative treatment with trastuzumab, can achieve a long-term tumor remission of several years.
This study included 30 patients with diagnosed rheumatoid arthritis (RA) and 30 test subjects without RA (control group). The objective of the study was to examine both groups for the presence of temporomandibular disorders (TMD) and morphological changes of the temporomandibular joint (TMJ). All individuals were examined using a systematic detailed clinical TMD examination as well as magnetic resonance imaging (MRI). The clinical TMD examination yielded significant differences between the RA patients and the control group concerning crepitus of the TMJ, and palpation tenderness of the masticatory muscles as well as the unassisted mandibular opening. The evaluation of the MRI images for the RA group showed significantly more frequent deformations of the condyle, osteophyte formations and erosions in the condylar compacta, and degenerative changes in the spongiosa. Increased intra-articular accumulation of synovial liquid and signs of inflammatory changes of the spongiosa were only found in the RA group. Statistical analysis showed a significant correlation between crepitus and specific osteoarthrotic changes (MRI), respectively, and between crepitus and a complete anterior disk displacement without reduction (MRI). The duration of the RA disease correlated neither with the anamnestic and clinical dysfunction index by Helkimo nor with RA-specific MRI findings.
Background: Diabetes mellitus and thyroid diseases frequently coexist. In order to evaluate how thyroid disorders interfere with glycemic control, we analysed insulin-treated type 2 diabetes patients with thyroid disease.
Methods: Diabetes patients (n = 1.957) were retrospectively investigated. We focused on type 2 diabetes patients who had been admitted for insulin-treatment and diagnosed thyroid diseases (n = 328). Patients were divided into three groups according to thyroid disease manifestation in relation to diabetes onset: prior to (group 1), same year (group 2) and thyroid disease following diabetes (group 3).
Results: Out of all diabetes patients 27.3% had a thyroid disorder with more women (62.2%) being affected (p < 0.001). Thyroid disease was predominantly diagnosed after diabetes onset. Patients with type 2 diabetes and prior appearance of thyroid disease required insulin therapy significantly earlier (median insulin-free period: 2.5 yrs; Q1 = 0.0, Q3 = 8.25) compared to patients who had thyroid dysfunction after diabetes onset (median insulin-free period: 8.0 yrs; Q1 = 3.0, Q3 = 12.0; p < 0.001). Age at diabetes onset correlated with insulin-free period (p < 0.001).
Conclusions: Thyroid disease may be a marker of a distinct metabolic trait in type 2 diabetes potentially requiring earlier insulin treatment.